• Instagram icon with link to IfADo's Instagram presence
  • X-Twitter icon with link to IfADo's X.com presence
  • Facebook icon with link to IfADo's Facebook presence
  • YouTube icon with link to IfADo's YouTube channel
  • LinkedIn icon with link to IfADo's LinkedIn presence
  • Mastodon icon with link to IfADo's Mastodon presence
Head of department
Prof. Dr. Jan G. Hengstler
Address
Ardeystr. 67
44139 Dortmund

Publications Toxicology

Lindskog C, Edlund K, Mattsson JS, Micke P:
Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use? Expert Rev Mol Diagn 15: 471-490 (2015)
Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pontén F:
Tissue-based map of the human proteome. Science 347 (6220): 1260419 (2015)
Birgisson H, Edlund K, Wallin U, Påhlman L, Kultima HG, Mayrhofer M, Micke P, Isaksson A, Botling J, Glimelius B, Sundström M:
Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer. BMC Cancer 15: 125 (2015) (11 pp)
Gerding J, Ali N, Schwartzbord J, Cramer B, Brown DL, Degen GH, Humpf H-U:
A comparative study of the human urinary mycotoxin excretion patterns in Bangladesh, Germany, and Haiti using a rapid and sensitive LC-MS/MS approach. Mycotoxin Res 31: 127-136 (20
Autrup H, Barile FA, Blaauboer BJ, Degen GH, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler JG, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Vermeulen NP:
Principles of pharmacology and toxicology also govern effects of chemicals on the endocrine system. Toxicol Sci 146: 11-15 (2015)
Gundert-Remy U, Barth H, Bürkle A, Degen GH, Landsiedel R:
Toxikologie in Deutschland 2015. Berlin: Gesellschaft für Toxikologie e.V., 2015
Bal-Price A, Crofton KM, Sachana M, Shafer TJ, Behl M, Forsby A, Hargreaves A, Landesmann B, Lein PJ, Louisse J, Monnet-Tschudi F, Paini A, Rolaki A, Schrattenholz A, Suñol C, van Thriel C, Whelan M, Fritsche E:
Putative adverse outcome pathways relevant to neurotoxicity. Crit Rev Toxicol 45: 83-91 (2015)
Pfeiffer E, Kegel V, Zeilinger K, Hengstler JG, Nüssler AK, Seehofer D, Damm G:
Featured Article: Isolation, characterization, and cultivation of human hepatocytes and non-parenchymal liver cells. Exp Biol Med (Maywood) 240: 645-656 (2015)
Thaler S, Thiede G, Hengstler JG, Schad A, Schmidt M, Sleeman JP:
The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer. Int J Cancer 137: 686-697 (2015)
Kim JY, Fluri DA, Marchan R, Boonen K, Mohanty S, Singh P, Hammad S, Landuyt B, Hengstler JG, Kelm JM, Hierlemann A, Frey O:
3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis. J Biotechnol 205: 24-35 (2015)